November 17, 2014
Predicting adverse drug reactions in patients with Multiple Sclerosis
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
The third annual Neuromyelitis Optica (NMO) Information Day will be held at the Djavad Mowafaghian Centre...
Dr. Haakon Nygaard comes to the Djavad Mowafaghian Centre for Brain Health (DMCBH) from...
For the better part of a century, the neurotransmitter dopamine has been understood as...
Dr. Dan Marigold is currently trying to determine how the brain adapts to altered...
Molecular geneticist Dr. Carles Vilarino-Guell has played an important role in the identification of...
Pictured:The dendrites of one neuron (red), and microglial cells (green). Researchers in Dr. Brian...
The quest to understand and treat Alzheimer’s disease is being bolstered intellectually and technologically...
Dr. Jack Taunton, professor in the Department of Family Practice and neurotrauma investigator at...
Led by Dr. Raymond Lam, researchers at the Mood Disorders Centre at UBC Hospital...
On September 12, delegates from 60 research sites and 23 countries will converge on...
Amyotophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating and...